RNA (SN117): What Holding It Means

RNA, identified by the symbol SN117, is listed in AI, Bittensor ecosystem and Bittensor subnet categories. Those labels do not establish what the token does: the project has not published a clear description of its purpose, how it fits into a subnet, or what holders can use it for. Treat it as a token with an unconfirmed role rather than assuming it grants access, governance rights or a share of revenue.

Before you consider holding or transferring it, confirm that the asset you are looking at is specifically RNA with the SN117 symbol. Several unrelated tokens use the name or ticker RNA, and a matching name alone is not enough to identify the right asset. Check the exact contract or network identifier against a reliable project-controlled source. If you cannot verify those details, do not send funds to an address claiming to support SN117.

The chain RNA (SN117) runs on has not been identified, and no official contract address or compatible wallet list is published. Category labels connecting it with Bittensor do not, by themselves, prove that SN117 is a Bittensor-native asset or tell you which wallet can hold it. Do not choose a network or copy a contract address based only on another token named RNA.

If you already hold SN117, check the network and contract shown in the wallet or exchange where you acquired it. For self-custody, use a wallet that explicitly supports that exact network and asset. Keep your recovery phrase offline and private; a legitimate support agent should never need it. For any transfer, first verify the receiving address, network and token identity. A small test transfer can help catch an address or network mistake, but it cannot make an unverified token safe. Blockchain transfers are generally difficult or impossible to reverse.

The reported maximum supply is 21 million SN117. Circulating and total supply are each about 2.90 million, as of 2026-11-08. That leaves a gap between current reported supply and the stated maximum, but the project has not published an issuance schedule explaining whether, when or under what conditions more tokens could enter circulation.

The reported price was about $1.35 and market capitalization about $3.9 million as of 2026-11-08; reported 24-hour trading volume was about $159,000. These are snapshots, not guaranteed sale prices, and thin or fragmented markets can make displayed values hard to realize. Check the trading venue, token identity and available liquidity before relying on a quote. The project has not published a tokenomics explanation that clarifies supply allocation, emissions, burns or any holder rights. None of these figures establishes future value.

The main risks are uncertainty about the token’s purpose and network, possible confusion with similarly named assets, and market volatility. Without a verified chain and contract, you may be unable to tell whether a wallet or exchange listing refers to SN117 or another RNA token. A project description and supply schedule are also not published, so you cannot assess the token’s intended role or how remaining supply might be introduced.

Before keeping it in self-custody, verify the asset details through a project-controlled channel and confirm wallet compatibility. Never share your recovery phrase or approve a transaction you do not understand. Check the destination and network carefully; sending tokens to an incompatible address may permanently lose them. Prices and trading access can change, and a quoted market value does not guarantee that you can sell at that price. Only hold an amount you can afford to lose, and do not treat category labels or past price movements as proof of utility or safety.